Skip to Main content Skip to Navigation
Journal articles

Methadone in primary care in France: Using evidence for action against hepatitis C

P. Roux 1 A. Morel 2 D. Wolfe 3 Patrizia Carrieri 1
1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
2 Association de prévention et de soin en addictologie - Oppelia [Paris]
3 OSI - Open Society Foundations
Abstract : In France, two opioid substitution treatments have been available since the mid-1990s: buprenorphine through primary care and specialized clinics, and methadone only through specialized clinics.
Keywords : Scientific evidence Advocacy Primary care Hepatitis C Methadone
Document type :
Journal articles
Complete list of metadata
https://hal-amu.archives-ouvertes.fr/hal-02613452
Contributor : Accord Elsevier Ccsd Connect in order to contact the contributor
Submitted on : Monday, October 25, 2021 - 12:56:20 PM
Last modification on : Wednesday, November 3, 2021 - 5:22:14 AM

File

Vignette du document
S0955395919301689.pdf
Files produced by the author(s)

Licence

Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Links full text

Elsevier-hosted Accepted Manuscript

Identifiers

Collections

UNIV-AMU | INSERM | U1252 | IRD

Citation

P. Roux, A. Morel, D. Wolfe, Patrizia Carrieri. Methadone in primary care in France: Using evidence for action against hepatitis C. International Journal of Drug Policy, Elsevier, 2019, 71, pp.91-92. ⟨10.1016/j.drugpo.2019.06.013⟩. ⟨hal-02613452⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

92

Files downloads

22